Stock analysts at Oppenheimer began coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a note issued to investors on Thursday, FlyOnTheWall reports. The firm set an “outperform” rating on the stock. A number of other equities analysts have also weighed in on OLMA. HC Wainwright dropped their price target on shares […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Rating) Director Cyrus Harmon sold 5,000 shares of the firm’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $6.04, for a total value of $30,200.00. Following the sale, the director now owns 1,053,714 shares in the company, valued at approximately […]
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) had its target price reduced by equities researchers at HC Wainwright from $15.00 to $14.00 in a report issued on Wednesday, The Fly reports. HC Wainwright’s target price indicates a potential upside of 105.88% from the company’s current price. Other equities research analysts have also issued reports about the […]
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) had its price target upped by Capital One Financial from $16.00 to $20.00 in a report released on Friday, The Fly reports. Capital One Financial‘s price target would indicate a potential upside of 190.28% from the stock’s current price. Several other equities research analysts also recently issued reports on […]
Capital One Financial started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) in a research note released on Friday, The Fly reports. The firm issued an overweight rating and a $16.00 target price on the stock. A number of other equities analysts have also recently weighed in on OLMA. Lifesci Capital reissued an […]